Anzeige
Mehr »
Freitag, 31.10.2025 - Börsentäglich über 12.000 News
Weltweiter Kaliboom treibt Nachfrage - ACM positioniert sich im 93,5 Mrd. USD-Markt bis 2032!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CUMB | ISIN: IT0005452658 | Ticker-Symbol: 87N
Frankfurt
30.10.25 | 21:55
21,200 Euro
-3,64 % -0,800
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
STEVANATO GROUP SPA Chart 1 Jahr
5-Tage-Chart
STEVANATO GROUP SPA 5-Tage-Chart
RealtimeGeldBriefZeit
21,40021,60030.10.
21,20021,80030.10.

Aktuelle News zur STEVANATO GROUP Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
22.10.Stevanato Group to Report Third Quarter 2025 Financial Results on November 6, 2025193Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced...
► Artikel lesen
21.10.Stevanato Group Expands Drug Delivery Systems Capacity to Strengthen Global Integrated Offerings289The investment enhances German facility to deliver more flexible and scalable drug delivery solutions Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug...
► Artikel lesen
12.09.Stevanato Group SpA (STVN) Share Gained 20% as Results Exceeded Expectations4
03.09.Stevanato Group S.p.A.: Stevanato Group to Participate in Upcoming Investor Conferences283Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today...
► Artikel lesen
25.08.Here's Why Artisan Small Cap Fund Increased its Holdings in Stevanato Group S.p.A. (STVN)1
12.08.Stevanato Group S.p.A. - 6-K, Report of foreign issuer4
STEVANATO GROUP Aktie jetzt für 0€ handeln
05.08.Stevanato Group S.p.A. - 6-K, Report of foreign issuer1
05.08.Stevanato Group S.p.A.: Stevanato Group Reports Revenue of €280.0 Million for the Second Quarter of 2025506Company delivers 8% revenue growth, expanded margins, and maintains fiscal year 2025 guidance Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery...
► Artikel lesen
23.07.Stevanato Group Secures $235.4 Million in Financing1
23.07.Stevanato secures €200 million financing for global expansion1
23.07.Stevanato secures €200M in financing1
23.07.Stevanato Group S.p.A.: Stevanato Group Secures €200 Million in Financing from BNL BNP Paribas, Cassa Depositi e Prestiti, and Banco BPM to Fund Ongoing CAPEX Investments in Italy and the U.S.746Stevanato Group S.p.A. (NYSE: STVN), a global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced...
► Artikel lesen
22.07.Stevanato Group S.p.A.: Stevanato Group to Report Second Quarter 2025 Financial Results on August 5, 2025340Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced...
► Artikel lesen
05.06.Stevanato Group auf Jefferies-Konferenz: Strategisches Wachstum und Expansion1
13.05.Stevanato Group S.p.A. - 6-K, Report of foreign issuer2
09.05.Stevanato Group S.p.A.: Stevanato Group to Participate in Upcoming Investor Conferences331Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today...
► Artikel lesen
08.05.Stevanato Group Non-GAAP EPS of €0.10 in-line, revenue of €256.6M misses by €23.36M5
08.05.Stevanato Group S.p.A.: Stevanato Group Reports Revenue of €256.6 Million for the First Quarter of 2025411Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today...
► Artikel lesen
05.05.Stevanato Group declares $0.0613 dividend3
24.04.Stevanato Group to Report First Quarter 2025 Financial Results on May 8, 2025371Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced...
► Artikel lesen
Weiter >>
26 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1